Cargando…
Effects of Glucagon-Like-Peptide-1 Analogue Treatment in Genetic Obesity
Introduction: Obesity is highly prevalent, comes with serious health burden and is difficult to treat. In a minority, there is a genetic cause for the obesity. In these patients, therapy-resistant obesity is often observed despite intensive lifestyle treatment. Moreover, it is still unclear whether...
Autores principales: | Welling, Mila Sofie, de Groot, Cornelis J, Kleinendorst, Lotte, van der Voorn, Bibian, Burgerhart, Jan Steven, van der Valk, Eline S, van Haelst, Mieke M, van den Akker, Erica L T, van Rossum, Elisabeth F C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265706/ http://dx.doi.org/10.1210/jendso/bvab048.065 |
Ejemplares similares
-
Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021) -
Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series
por: Welling, Mila S., et al.
Publicado: (2021) -
FRI046 Clinical Phenotyping Of Adults With Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2023) -
Hair Cortisol, Obesity and the Immune System: Results From a 3 Year Longitudinal Study
por: van der Valk, Eline S, et al.
Publicado: (2021) -
The Relation Between Cortisol and Anthropometric Measurements Throughout Lifespan: A Systematic Review and Meta-Analysis
por: van der Valk, Eline S, et al.
Publicado: (2021)